Abstract
The DGS/DHOS/Afssaps circular No. 03/582 of December 15, 2003 has regulated the performance of the transfusion act since 2003. The French Society for Vigilance and Transfusion Therapy (SFVTT) requested the revision of this text from the Directorate General for Health (DGS) in November 2018. Indeed, the new requirements in terms of transfusion safety of the Public Health Code, the National Agency for the Safety of Medicines and Health Products, the High Authority for health, and the desire to deploy patient blood management have have caused practices to evolve. Following the agreement of the DGS, an SFVTT working group was set up, with the objective of redrafting the guidelines. This approach led to the publication of the new instruction No. DGS/PP4/DGOS/PF2/2021/230 of November 16, 2021 relating to the performance of the transfusion act, 18years after that of the first circular.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
